Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Tamoxifen derivative shows promise as new treatment for common breast cancer type

Tamoxifen derivative shows promise as new treatment for common breast cancer type

Identifying similarities between next-generation prostate cancer drugs

Identifying similarities between next-generation prostate cancer drugs

NICE recommends trastuzumab emtansine for HER2 breast cancer in England, reversing previous provisional rejection

NICE recommends trastuzumab emtansine for HER2 breast cancer in England, reversing previous provisional rejection

Abiraterone acetate responses even after initial hormone therapy failure

Abiraterone acetate responses even after initial hormone therapy failure

AACR 2017: New therapeutic shows pre-clinical efficacy against castration resistant prostate cancer

AACR 2017: New therapeutic shows pre-clinical efficacy against castration resistant prostate cancer

Researchers discover key to drug resistance in common breast cancer treatment

Researchers discover key to drug resistance in common breast cancer treatment

Long term study of oral contraceptive finds chemo-prevention of some cancers

Long term study of oral contraceptive finds chemo-prevention of some cancers

Shorter herceptin breast cancer treatment may produce better results

Shorter herceptin breast cancer treatment may produce better results

Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peritoneum cancer

Hormonal maintenance therapy may improve survival in women with chemo-resistant rare ovarian or peritoneum cancer

New approach to cervical cancer care in Botswana halves time between treatment and diagnosis

New approach to cervical cancer care in Botswana halves time between treatment and diagnosis

More from ecancer